Benjamin O'Callaghan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Benjamin O'Callaghan has a total of 329 co-authors. Here are the top co-authors by number of shared publications:
Helene Plun-Favreau
13 shared publications- Helene Plun-Favreau
UCL Queen Square Institute of Neurology
10 shared publications - Marc P. M. Soutar
UCL Queen Square Institute of Neurology
7 shared publications - Sonia Gandhi
Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK
7 shared publications - Henry Houlden
UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery
6 shared publications - Capucine de Talhouet
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK
5 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Springer Nature
Measurements of Lysosomal pH Using FIRE-pHLy SH-SY5Ys v1
Protocol outlining the measurement of lysosomal pH using the ratiometric biosensor FIRE-pHLy in SH-SY5Y cells, and the sensitivity of lysosomal pH following siRNA mediated knockdown of specific target genes. This protocol measures relative lysosomal pH in SH-SY5Y neuroblastoma cells following siRNA knockdown, using the genetically encoded ratiometric biosensor FIRE-pHLy and high-content confocal imaging on an Opera Phenix. FIRE-pHLY consists of LAMP1 conjugated to a lysosomal lumen facing pH-sensitive mTFP1, which is quenched in high acidity, and a cytosolic-facing mCherry, meaning that changes in the mTFP1:mCherry fluorescent ratio reflect variation in lysosomal pH (https://doi.org/10.1021/acssensors.0c02318). This protocol describes: 1) production of FIRE-pHLy lentivirus in Lenti-X 293T cells; 2) reverse transduction and establishment of stable FIRE-pHLy SH-SY5Y line; 3) reverse siRNA transfection and live-cell ratiometric imaging with Columbus analysis for lysosomal pH measurements.
- 22 October 2026
- Published by Springer Nature
Open AccessMeasurements of Lysosomal pH Using FIRE-pHLy SH-SY5Ys v1
Protocol outlining the measurement of lysosomal pH using the ratiometric biosensor FIRE-pHLy in SH-SY5Y cells, and the sensitivity of lysosomal pH following siRNA mediated knockdown of specific target genes. This protocol measures relative lysosomal pH in SH-SY5Y neuroblastoma cells following siRNA knockdown, using the genetically encoded ratiometric biosensor FIRE-pHLy and high-content confocal imaging on an Opera Phenix. FIRE-pHLY consists of LAMP1 conjugated to a lysosomal lumen facing pH-sensitive mTFP1, which is quenched in high acidity, and a cytosolic-facing mCherry, meaning that changes in the mTFP1:mCherry fluorescent ratio reflect variation in lysosomal pH (https://doi.org/10.1021/acssensors.0c02318). This protocol describes: 1) production of FIRE-pHLy lentivirus in Lenti-X 293T cells; 2) reverse transduction and establishment of stable FIRE-pHLy SH-SY5Y line; 3) reverse siRNA transfection and live-cell ratiometric imaging with Columbus analysis for lysosomal pH measurements.
- Open Access
- 12 June 2026
- Published by Taylor & Francis in Autophagy Reports
- Vol. 5 (1)
Glucose concentration of neuronal media formulations influences PINK1-dependent mitophagy in human iNeurons
Parkinson’s disease-associated proteins PINK1 and Parkin collaboratively regulate stress-induced mitophagy. While in vitro human neuronal cultures are valuable for studying the roles of PINK1 and Parkin in a disease-relevant context, the impact of culture conditions on these processes remains largely underexplored. Here, it is shown that human induced neurons (iNeurons) cultured in N2B27 and BrainPhys medium exhibit distinct PINK1-Parkin–dependent mitophagy phenotypes. Specifically, BrainPhys-cultured iNeurons show greater resistance to PINK1-dependent mitophagy initiation, linked to a reduction in glucose availability and reduced PINK1 protein availabilities, leading to decreases in stress-induced and basal mitophagy fluxes. These findings highlight the critical impact of culture conditions on mitophagy dynamics and emphasize the need to account for media-specific differences when using in vitro models to investigate mitophagy mechanisms in human neurons.
- 12 June 2026
- Published by Taylor & Francis in Autophagy Reports
- Vol. 5 (1)
Open AccessGlucose concentration of neuronal media formulations influences PINK1-dependent mitophagy in human iNeurons
Parkinson’s disease-associated proteins PINK1 and Parkin collaboratively regulate stress-induced mitophagy. While in vitro human neuronal cultures are valuable for studying the roles of PINK1 and Parkin in a disease-relevant context, the impact of culture conditions on these processes remains largely underexplored. Here, it is shown that human induced neurons (iNeurons) cultured in N2B27 and BrainPhys medium exhibit distinct PINK1-Parkin–dependent mitophagy phenotypes. Specifically, BrainPhys-cultured iNeurons show greater resistance to PINK1-dependent mitophagy initiation, linked to a reduction in glucose availability and reduced PINK1 protein availabilities, leading to decreases in stress-induced and basal mitophagy fluxes. These findings highlight the critical impact of culture conditions on mitophagy dynamics and emphasize the need to account for media-specific differences when using in vitro models to investigate mitophagy mechanisms in human neurons.
- Open Access
- 15 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality
Dissecting biological pathways highlighted by Mendelian gene discovery has provided critical insights into the pathogenesis of Parkinson’s disease (PD) and neurodegeneration. This approach ultimately catalyzes the identification of potential biomarkers and therapeutic targets. Here we identify PSMF1 as a gene implicated in parkinsonism and childhood neurodegeneration. We find that biallelic PSMF1 missense and loss-of-function variants co-segregate with phenotypes from early-onset PD to perinatal lethality with neurological manifestations across 18 pedigrees with 25 affected subjects, showing clear genotype-phenotype correlation. PSMF1 encodes the proteasome regulator PSMF1/hPI31, a highly conserved, ubiquitously expressed partner of the 20S proteasome and neurodegeneration-associated F-box-O 7 and valosin-containing proteins. We demonstrate that PSMF1 variants may affect proteasomal abundance and assembly, and are associated with alterations of mitochondrial membrane potential, respiration, dynamics and mitophagy in patient-derived fibroblasts. Furthermore, Drosophila and mouse models of PI31 loss of function exhibit age-dependent motor impairment, as well as brain-wide mitochondrial membrane depolarization and dopaminergic neurodegeneration in aged flies, and diffuse gliosis in mice. Collectively, our findings unequivocally link defective PSMF1/hPI31 to early-onset parkinsonism and neurodegeneration, and suggest proteasomal and mitochondrial dysfunction as pathogenic contributors.
- 15 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessVariants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality
Dissecting biological pathways highlighted by Mendelian gene discovery has provided critical insights into the pathogenesis of Parkinson’s disease (PD) and neurodegeneration. This approach ultimately catalyzes the identification of potential biomarkers and therapeutic targets. Here we identify PSMF1 as a gene implicated in parkinsonism and childhood neurodegeneration. We find that biallelic PSMF1 missense and loss-of-function variants co-segregate with phenotypes from early-onset PD to perinatal lethality with neurological manifestations across 18 pedigrees with 25 affected subjects, showing clear genotype-phenotype correlation. PSMF1 encodes the proteasome regulator PSMF1/hPI31, a highly conserved, ubiquitously expressed partner of the 20S proteasome and neurodegeneration-associated F-box-O 7 and valosin-containing proteins. We demonstrate that PSMF1 variants may affect proteasomal abundance and assembly, and are associated with alterations of mitochondrial membrane potential, respiration, dynamics and mitophagy in patient-derived fibroblasts. Furthermore, Drosophila and mouse models of PI31 loss of function exhibit age-dependent motor impairment, as well as brain-wide mitochondrial membrane depolarization and dopaminergic neurodegeneration in aged flies, and diffuse gliosis in mice. Collectively, our findings unequivocally link defective PSMF1/hPI31 to early-onset parkinsonism and neurodegeneration, and suggest proteasomal and mitochondrial dysfunction as pathogenic contributors.
- Open Access
- 25 February 2026
- Published by Springer Nature
Measuring Mitochondrial Membrane Potential in iNeurons Through Live-Cell TMRM Imaging v1
Protocol outlining the measurement of mitochondrial membrane potential in iNeurons and the sensitivity of the mitochondrial membrane potential to application of mitochondrial toxins, through live-cell imaging of TMRM in mitoSRAI expressing iNeurons.
- 25 February 2026
- Published by Springer Nature
Open AccessMeasuring Mitochondrial Membrane Potential in iNeurons Through Live-Cell TMRM Imaging v1
Protocol outlining the measurement of mitochondrial membrane potential in iNeurons and the sensitivity of the mitochondrial membrane potential to application of mitochondrial toxins, through live-cell imaging of TMRM in mitoSRAI expressing iNeurons.
- Open Access
TDP-43 loss of function drives aberrant splicing in Parkinson’s disease
Introductory paragraph: While mRNA splicing dysregulation is a well-established contributor to neurodegeneration in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), its role in Parkinson’s disease (PD) remains underexplored. Here, we analyse transcriptomic data from >500 post-mortem human brain samples from individuals with and without PD to show that splicing alterations are frequently detected. Differentially spliced genes were significantly more enriched for those causally-implicated in both PD and ALS than genes that were differentially expressed. Furthermore, we observed a strong association between these splicing alterations and dysfunction of the RNA-binding protein (RBP), TAR DNA-binding protein 43 (TDP-43). Strikingly, genes and exon junctions affected by TDP-43 knockdown overlapped significantly with those dysregulated across brain regions in PD. In brains from individuals with the LRRK2 c.6055G>A (p.G2019S) mutation, the most common genetic cause of PD, we also observed significant enrichment of TDP-43-dependent splicing changes. This finding was corroborated in human pluripotent stem cell-derived midbrain dopaminergic neurons and a LRRK2 p.G2019S knock-in mouse model, where reduced nuclear TDP-43 levels evidenced the well-recognised loss-of-function mechanism contributing to splicing dysregulation. By leveraging our RNA-based analyses we predicted TDP-43-dependent novel peptide sequences and validated their existence within human LRRK2 mutation mDNs, while also demonstrating an overall loss of protein and mRNA expression in mis-spliced genes. Collectively, our findings reveal that PD is marked by extensive splicing dysregulation dependent on TDP-43, making TDP-43 a promising new therapeutic target in PD.
Open AccessTDP-43 loss of function drives aberrant splicing in Parkinson’s disease
Introductory paragraph: While mRNA splicing dysregulation is a well-established contributor to neurodegeneration in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), its role in Parkinson’s disease (PD) remains underexplored. Here, we analyse transcriptomic data from >500 post-mortem human brain samples from individuals with and without PD to show that splicing alterations are frequently detected. Differentially spliced genes were significantly more enriched for those causally-implicated in both PD and ALS than genes that were differentially expressed. Furthermore, we observed a strong association between these splicing alterations and dysfunction of the RNA-binding protein (RBP), TAR DNA-binding protein 43 (TDP-43). Strikingly, genes and exon junctions affected by TDP-43 knockdown overlapped significantly with those dysregulated across brain regions in PD. In brains from individuals with the LRRK2 c.6055G>A (p.G2019S) mutation, the most common genetic cause of PD, we also observed significant enrichment of TDP-43-dependent splicing changes. This finding was corroborated in human pluripotent stem cell-derived midbrain dopaminergic neurons and a LRRK2 p.G2019S knock-in mouse model, where reduced nuclear TDP-43 levels evidenced the well-recognised loss-of-function mechanism contributing to splicing dysregulation. By leveraging our RNA-based analyses we predicted TDP-43-dependent novel peptide sequences and validated their existence within human LRRK2 mutation mDNs, while also demonstrating an overall loss of protein and mRNA expression in mis-spliced genes. Collectively, our findings reveal that PD is marked by extensive splicing dysregulation dependent on TDP-43, making TDP-43 a promising new therapeutic target in PD.
- Open Access
Glucose concentration of neuronal media formulations influences PINK1-dependent mitophagy in human iNeurons
Parkinson’s disease associated proteins PINK1 and Parkin collaboratively regulate stress-induced mitophagy. While in vitro human neuronal cultures are valuable for studying the roles of PINK1 and Parkin in a disease-relevant context, the impact of culture conditions on these processes remains largely underexplored. Here, it is shown that human induced neurons (iNeurons) cultured in N2B27 and BrainPhys medium exhibit distinct PINK1-Parkin dependent mitophagy phenotypes. Specifically, BrainPhys-cultured iNeurons show greater resistance to PINK1-dependent mitophagy initiation, linked to a reduction in glucose availability and reduced PINK1 protein availabilities, leading to decreases in stress-induced and basal mitophagy fluxes. These findings highlight the critical impact of culture conditions on mitophagy dynamics and emphasise the need to account for media-specific differences when using in vitro models to investigate mitophagy mechanisms in human neurons.
Open AccessGlucose concentration of neuronal media formulations influences PINK1-dependent mitophagy in human iNeurons
Parkinson’s disease associated proteins PINK1 and Parkin collaboratively regulate stress-induced mitophagy. While in vitro human neuronal cultures are valuable for studying the roles of PINK1 and Parkin in a disease-relevant context, the impact of culture conditions on these processes remains largely underexplored. Here, it is shown that human induced neurons (iNeurons) cultured in N2B27 and BrainPhys medium exhibit distinct PINK1-Parkin dependent mitophagy phenotypes. Specifically, BrainPhys-cultured iNeurons show greater resistance to PINK1-dependent mitophagy initiation, linked to a reduction in glucose availability and reduced PINK1 protein availabilities, leading to decreases in stress-induced and basal mitophagy fluxes. These findings highlight the critical impact of culture conditions on mitophagy dynamics and emphasise the need to account for media-specific differences when using in vitro models to investigate mitophagy mechanisms in human neurons.
- Open Access
17q21.31 locus regulates Parkinson’s disease relevant pathways through KANSL1 activity
An inversion polymorphism at the 17q21.31 locus defines the H1 and H2 haplotypes, with the former linked to multiple neurodegenerative disorders, including an increased risk of Parkinson’s disease (PD). Although the high linkage disequilibrium at this locus has made it difficult to decipher which gene(s) drive the PD association, there is increasing evidence to support the role of KANSL1 as a risk gene. KANSL1 has been shown to regulate the expression of some PD-associated genes and pathways, likely as part of the histone acetylating non-specific lethal (NSL) complex. Here for the first time, we studied the global effects of 17q21.31 haplotype variation using bulk and single-nuclear RNA-sequencing data from control and PD patient brain. We first analysed differential gene expression across haplotype groups, and then assessed the contribution of KANSL1 by comparing with the results of an siRNA knockdown in neuronal and glial human cell lines. We demonstrated that the PD risk-associated H1 haplotype downregulates autophagy, lysosomal and mitochondrial processes, all of which have already been implicated in PD aetiology. Furthermore, these effects were apparent in both neuronal and glial cell types, and in the case of the latter, appear to be associated with the modulation of innate and adaptive immune responses. Thus, we identify important links between NSL complex activity and PD pathophysiology that can be leveraged for novel therapeutic interventions.
Open Access17q21.31 locus regulates Parkinson’s disease relevant pathways through KANSL1 activity
An inversion polymorphism at the 17q21.31 locus defines the H1 and H2 haplotypes, with the former linked to multiple neurodegenerative disorders, including an increased risk of Parkinson’s disease (PD). Although the high linkage disequilibrium at this locus has made it difficult to decipher which gene(s) drive the PD association, there is increasing evidence to support the role of KANSL1 as a risk gene. KANSL1 has been shown to regulate the expression of some PD-associated genes and pathways, likely as part of the histone acetylating non-specific lethal (NSL) complex. Here for the first time, we studied the global effects of 17q21.31 haplotype variation using bulk and single-nuclear RNA-sequencing data from control and PD patient brain. We first analysed differential gene expression across haplotype groups, and then assessed the contribution of KANSL1 by comparing with the results of an siRNA knockdown in neuronal and glial human cell lines. We demonstrated that the PD risk-associated H1 haplotype downregulates autophagy, lysosomal and mitochondrial processes, all of which have already been implicated in PD aetiology. Furthermore, these effects were apparent in both neuronal and glial cell types, and in the case of the latter, appear to be associated with the modulation of innate and adaptive immune responses. Thus, we identify important links between NSL complex activity and PD pathophysiology that can be leveraged for novel therapeutic interventions.
- Open Access
- 4 March 2025
- Published by Springer Nature
iNeuron RNA-Extraction and RT-qPCR v1
Protocol for the extraction of RNA from iNeurons and RT-qPCR measurements of PINK1 mRNA.
- 4 March 2025
- Published by Springer Nature
Open AccessiNeuron RNA-Extraction and RT-qPCR v1
Protocol for the extraction of RNA from iNeurons and RT-qPCR measurements of PINK1 mRNA.
- Open Access
- 4 March 2025
- Published by Springer Nature
Immunofluorescence Staining for Assessing pUb(Ser65) Accumulation in iNeurons v1
Protocol for the imaging and analysis of iNeurons with anti-pUb(Ser65) immunofluorescence in order to measure PINK1-dependent mitophagy initiation.
- 4 March 2025
- Published by Springer Nature
Open AccessImmunofluorescence Staining for Assessing pUb(Ser65) Accumulation in iNeurons v1
Protocol for the imaging and analysis of iNeurons with anti-pUb(Ser65) immunofluorescence in order to measure PINK1-dependent mitophagy initiation.
- Open Access
- 4 March 2025
- Published by Springer Nature
Immunoblot Assessments of PINK1-Dependent Mitophagy in iNeurons v1
Protocol outlining the use of immunoblots for assessment of the PINK1-dependent mitophagy process in iNeurons.
- 4 March 2025
- Published by Springer Nature
Open AccessImmunoblot Assessments of PINK1-Dependent Mitophagy in iNeurons v1
Protocol outlining the use of immunoblots for assessment of the PINK1-dependent mitophagy process in iNeurons.